Increased serum C‐reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E311-E319

John Wiley & Sons Inc

Access to resources Recommend Favorite

C-Reactive Protein is a Prognostic Marker for Patients with Castration-Resistant Prostate Cancer

By  

Oncology Research and Treatment, Vol. 39, Iss. 5, 2016-04 ,pp. : 266-271

Karger

Access to resources Recommend Favorite

Cystatin C levels in sera of patients with acute infectious diseases with high C-reactive protein levels

By Randers E.   Kornerup K.   Erlandsen E. J.   Hasling C.   Danielsen H.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 61, Iss. 4, 2001-06 ,pp. : 333-335

Informa Healthcare

Access to resources Recommend Favorite

Levels of C-Reactive Protein and Protein C in Periodontitis Patients with and without Cardiovascular Disease

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 37, Iss. 1, 2010-07 ,pp. : 49-54

Karger

Access to resources Recommend Favorite

Prognostic Impact of Intratumoral C-Reactive Protein Expression in Patients with Clear Cell Renal Cell Carcinoma

By  

Urologia Internationalis, Vol. 92, Iss. 3, 2013-12 ,pp. : 270-275

Karger

Access to resources Recommend Favorite